Hereditary Cancer Predisposition: The Evolving Li-Fraumeni Syndrome Market for Genetic Oncology Disorders
Hereditary cancer predisposition syndromes represent a critical area of genetic oncology, with significant implications for cancer prevention, early detection, and management. Li-Fraumeni syndrome, a rare condition caused by TP53 mutations, exemplifies the challenges and opportunities in managing hereditary cancer predisposition. The treatment market is experiencing steady growth, with...
0 Comments 0 Shares 179 Views 0 Reviews